Table A1. COD Discharges and Its Determinants with Station Fixed Effects Independent variables (1) (2) (3) (4) (5) Boundary×Post2005 -2.138** -2.012** (0.923) (0.898) Boundary ×Time_Trend -0.543*** (0.209) Proximity to Boundary ×Post2005 -0.129*** (0.044) Proximity to Boundary ×Time_Trend -0.052*** (0.011) Station dummy Yes Yes Yes Yes Yes Year dummy Yes Yes Yes Yes Yes Temperature Yes Yes Ye...

CNS involvement Encephalopathy Yes Yes [Lamperti 2012] Dystonia Yes Yes [Carrozza 2016] Spasticity Yes Yes [Carrozza 2016] Choreoathetosis Yes No [Ostergaard 2007] Migraine Yes No No Developmental delay Yes Yes [Carrozza 2016] Irritability Yes No [Lamperti 2012] Hypotonia Yes Yes [Carrozza 2016] Perturbed sleep/wake cycle No Yes No Dysarthria/anarthria Yes Yes [Lamperti 2012] Basal ganglia invo...

Sitagliptin is a dipeptidyl peptidase-4 (DPP IV, CD26) inhibitor indicated for treatment of Type II diabetes as a second line therapy after metformin. We report fifteen sitagliptin intolerant patients who developed anterior and posterior rhinorrhea, cough, dyspnea, and fatigue. Symptoms typically developed within 1 to 8 weeks of starting, and resolved within 1 week of stopping the drug. Peak ex...

Fever ≥38.5°C No/U Yes 0 Enlarged lymph nodes No/U Yes 0 Eosinophils No/U 0.7–1.499 × 109l–1 ≥ 1.5× 109l–1 1 Atypical lymphocytes No/U Yes 1 Skin involvement 2 Skin rash extent (% body surface area) No/U > 50% Skin rash suggesting DRESS No/U Yes Biopsy suggesting DRESS No Yes/U Organ involvementa 2 Liver No/U Yes Yes Kidney No/U Yes No/U Lung No/U Yes Yes Muscle/heart No/U Yes No/U Pancreas No/...